Citadel Advisors’s Vaxart VXRT Stock Holding History
Bought
Maintained
Sold
Other funds holding VXRT
XT
HSA
BCMLT
CFO
LCM
HWA
Citadel Advisors's VXRT Position: Q1 2025 in Review
Citadel Advisors sold out of Vaxart (VXRT) in Q1 2025, closing a stake of 501,623 shares — an estimated $322K sold.
Citadel Advisors first reported a position in VXRT in Q1 2014 and held it in 23 quarters. The position peaked at $27.4M in Q2 2020. 92 funds tracked by Wall St. Rank hold VXRT as of Q1 2025.
- Citadel Advisors reported no remaining Vaxart position as of Q1 2025 after selling out during the quarter.
- Citadel Advisors sold 501,623 Vaxart shares in Q1 2025, an estimated $322K.
- Citadel Advisors first reported a position in Vaxart in Q1 2014 and held it in 23 quarters.
- Citadel Advisors's Vaxart position peaked at $27.4M in Q2 2020.
- 92 funds tracked by Wall St. Rank held Vaxart as of Q1 2025.
Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.